A review from Anglia Ruskin University, summarized in a Knowridge analysis of GLP-1 drugs and Alzheimers prevention, looked at 30 earlier studies covering liraglutide, semaglutide, exenatide, and dulaglutide
National Library of Medicine)
Xarelto is also contraindicated, meaning not advisable, for use by patients with active bleeding conditions or severe hypersensitivity (allergic reaction, such as anaphylaxis) to Xarelto (rivaroxaban) or any of its other ingredients
Common side effects include nausea, vomiting, and gastrointestinal changeseffects that usually diminish after the first 2-4 weeks but warrant discussion with your healthcare provider
Ralph DeFronzo Globally Certified Approved by multiple national health authorities
Feedback from users offers insight into its effectiveness and potential drawbacks